Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kruti Vora"'
Publikováno v:
MedEdPublish, Vol 10, Iss 1 (2021)
With nearly half the world’s population using social media, platforms like Instagram, Twitter, and Facebook have become popular sources of information gathering and sharing for the general public. In medicine, social media is increasingly used to e
Externí odkaz:
https://doaj.org/article/264f5a237e73498dabda2612da8aa62d
Autor:
Michael Dougan, Elizabeth I. Buchbinder, Meredith Davis, Anita Giobbie-Hurder, William Martin-Doyle, Patrick A. Ott, Osama E. Rahma, Maria Gargano, F. Stephen Hodi, Shilpa Grover, Rawad Elias, Rizwan Haq, Taha Qazi, Kruti Vora, Steven M. Blum, Jeffrey J. Ishizuka, Kevin Tyan, Ryan J. Sullivan, Michael Manos, Lauren Eastman, Alex B. Ruan
Publikováno v:
Cancer
Background There is a lack of predictive markers informing on the risk of colitis in patients treated with immune checkpoint inhibitors (ICIs). The aim of this study was to identify potential factors associated with development of ICI colitis. Method
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Emerging retrospective and prospective studies indicate that immune checkpoint inhibitors (ICIs) can be safe and effective cancer treatments among people living with human immunodeficiency virus (PLWH), however this high-cancer-risk population has of
Publikováno v:
MedEdPublish, Vol 10, Iss 1 (2021)
With nearly half the world’s population using social media, platforms like Instagram, Twitter, and Facebook have become popular sources of information gathering and sharing for the general public. In medicine, social media is increasingly used to e
Autor:
Kruti Vora, Mark M. Awad
Publikováno v:
Journal of Clinical Oncology. 38:e19035-e19035
e19035 Background: Although patients living with HIV are at increased risk for developing several cancers, they have often been excluded from practice-changing immunotherapy clinical trials across many tumor types. Emerging retrospective and prospect
Autor:
Elizabeth I. Buchbinder, Taha Qazi, Michael Dougan, Jeffrey J. Ishizuka, Lauren Eastman, Osama E. Rahma, Kevin Tyan, Kruti Vora, William Martin-Doyle, Meredith Davis, Rizwan Haq, F. Stephen Hodi, Ryan J. Sullivan, Anita Giobbie-Hurder, Alex B. Ruan, Maria Gargano, Shilpa Grover, Rawad Elias, Steven M. Blum, Patrick A. Ott
Publikováno v:
Journal of Clinical Oncology. 38:89-89
89 Background: There is a lack of predictive markers informing on the risk of colitis in patients treated with immune checkpoint inhibitors (ICIs). The aim of this study was to identify potential factors associated with development of ICI colitis. Me